OpenAlex 3.136 eser 63 yazar konusu
Çalışmalar
3.136 eser
-
Paraneoplastic anti N methyl D aspartate receptor encephalitis associated with ovarian teratoma 2007YÖKSİS SJR Q1 JCR Q1 OpenAlex üst %1 OpenAlex 100.0%
OBJECTIVE: To report the autoantigens of a new category of treatment-responsive paraneoplastic encephalitis. METHODS: Analysis of clinical features, neuropathological findings, tumors, and serum/cerebrospinal fluid antibodies using rat tissue, neuronal cultures, and HEK293 cells expressing subunits of the N-methyl-D-a…
-
YÖKSİS
SJR Q1
JCR Q1
OpenAlex üst %1
OpenAlex 100.0%
BACKGROUND: B cells influence the pathogenesis of multiple sclerosis. Ocrelizumab is a humanized monoclonal antibody that selectively depletes CD20+ B cells. METHODS: In two identical phase 3 trials, we randomly assigned 821 and 835 patients with relapsing multiple sclerosis to receive intravenous ocrelizumab at a dos…
-
YÖKSİS
SJR Q1
JCR Q1
OpenAlex üst %1
OpenAlex 99.9%
BACKGROUND: Interferon beta is used to modify the course of relapsing multiple sclerosis. Despite interferon beta therapy, many patients have relapses. Natalizumab, an alpha4 integrin antagonist, appeared to be safe and effective alone and when added to interferon beta-1a in preliminary studies. METHODS: We randomly a…
-
YÖKSİS
SJR Q1
JCR Q1
OpenAlex üst %1
OpenAlex 99.9%
BACKGROUND: Interferon beta is used to modify the course of relapsing multiple sclerosis. Despite interferon beta therapy, many patients have relapses. Natalizumab, an alpha4 integrin antagonist, appeared to be safe and effective alone and when added to interferon beta-1a in preliminary studies. METHODS: We randomly a…
-
YÖKSİS
SJR Q1
JCR Q1
OpenAlex üst %1
OpenAlex 99.9%
Özet henüz yok.
-
YÖKSİS
SJR Q1
JCR Q1
OpenAlex üst %1
OpenAlex 99.9%
Özet henüz yok.
-
YÖKSİS
SJR Q1
JCR Q1
OpenAlex üst %1
OpenAlex 99.9%
Özet henüz yok.
-
YÖKSİS
SJR Q1
JCR Q1
OpenAlex üst %1
OpenAlex 99.9%
Özet henüz yok.
-
YÖKSİS
SJR Q1
JCR Q1
OpenAlex üst %1
OpenAlex 99.9%
Özet henüz yok.
-
YÖKSİS
SJR Q1
JCR Q1
OpenAlex üst %1
OpenAlex 99.9%
Özet henüz yok.
-
YÖKSİS
SJR Q1
JCR Q1
OpenAlex üst %1
OpenAlex 99.9%
BACKGROUND: Ofatumumab, a subcutaneous anti-CD20 monoclonal antibody, selectively depletes B cells. Teriflunomide, an oral inhibitor of pyrimidine synthesis, reduces T-cell and B-cell activation. The relative effects of these two drugs in patients with multiple sclerosis are not known. METHODS: In two double-blind, do…
-
YÖKSİS
SJR Q1
JCR Q1
OpenAlex üst %1
OpenAlex 99.9%
Importance: Within 2 decades of onset, 80% of untreated patients with relapsing-remitting multiple sclerosis (MS) convert to a phase of irreversible disability accrual termed secondary progressive MS. The association between disease-modifying treatments (DMTs), and this conversion has rarely been studied and never usi…
Akademisyenler
63 akademisyen
- MURAT TERZİ 78 yazar konusu
- CAVİT BOZ 66 yazar konusu
- AYSUN SOYSAL 41 yazar konusu
- ABDULKADİR TUNÇ 21 yazar konusu
- HESNA BEKTAŞ 18 yazar konusu
- TAHİR KURTULUŞ YOLDAŞ 18 yazar konusu
- GÖNÜL VURAL 17 yazar konusu
- ÇAĞRI MESUT TEMUÇİN 16 yazar konusu
- SEDAT ŞEN 16 yazar konusu
- ATAY VURAL 14 yazar konusu
- FARUK İNCECİK 13 yazar konusu
- AYŞE FAHRİYE TOSUN 12 yazar konusu